Plastic Surgeons Get Tips on Managing Opioid Addiction Risk
Article ID: 682076
Released: 2-Oct-2017 11:35 AM EDT
Source Newsroom: Wolters Kluwer Health: Lippincott Williams and Wilkins
Newswise — October 2, 2017 – Opioid medications prescribed for pain management after plastic surgery may contribute to the ongoing opioid epidemic, according to a special topic paper in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Plastic surgeons must recognize their patients' risk of developing opioid use disorders and that the opioids they prescribe may be diverted to non-medical use, according to the article by Daniel Demsey, MD, of University of British Columbia, Vancouver, and colleagues.
"Surgeon opioid prescribing practices contribute to the opioid addiction crisis," Dr. Demsey said. "Improvements in prescribing practices can improve patient safety."
Managing the Risks
As for other types of surgery, patients undergoing plastic and reconstructive surgery are commonly prescribed opioid medications to manage postoperative pain. In recent years, increased opioid prescribing has been closely linked to increases in opioid overdose.
"The scale of the opioid addiction epidemic is difficult to exaggerate," according to Dr. Demsey and coauthors. They cite studies reporting that 4.7 percent of the U.S. population aberrantly used prescription opioids in 2015. In the same year, nearly 29,000 people died due to prescription opioid overdose.
Opioids prescribed after surgery contribute to the opioid crisis in two ways: by exposing patients to potentially addictive medications and by contributing to the street supply of opioid drugs. Patients with previous chronic opioid use are more likely to still be taking these drugs one year after surgery. Even patients who have never taken opioids before are at risk of persistent use.
Risk factors for persistent opioid use include previous substance use disorders, mental health problems such as anxiety or depression, female sex and low socioeconomic status. Patients with chronic pain who are already taking opioids are at higher risk of complications or death after major surgery and incur higher health care costs.
Many patients don't use all the opioid medications prescribed after surgery, with a risk that these leftover drugs will be diverted to nonmedical use by the patient or others. Most people with prescription opioid use disorder get the drugs from friends and family.
Dr. Demsey and coauthors suggest strategies for plastic surgeons to reduce the risks of persistent opioid use or diversion. Patients should be screened for risk factors for opioid use disorder; talking to patients about these risks in a nonjudgmental way may encourage them to use their pain medications cautiously. The patient's primary care doctor should also be informed about the possible increase in risk.
For patients at risk, outcomes can be improved by referral to a transitional pain service, including development of an opioid weaning plan. Patients with known or suspected substance use disorder should be referred to an addiction specialist, preferably before surgery.
The authors said, "Elective surgery in patients with established substance use disorders should not be performed until follow-up for substance use has been arranged."
Other strategies can help to reduce the need for opioids, including the use of combination anesthesia techniques and prescribing nonopioid pain medications after surgery. Educating patients about proper storage and disposal of opioid medications can help to reduce the risk of persistent opioid use or diversion.
Dr. Demsey said, "Although we cannot solve the opioid addiction crisis on our own, as plastic surgeons we can make a major contribution."
Article: “Managing Opioid Addiction Risk in Plastic Surgery during the Perioperative Period” (doi: 10.1097/PRS.0000000000003742)
About Plastic and Reconstructive Surgery
For more than 70 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in more than 180 countries, maintains operations in more than 40 countries and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the health care industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like on Facebook, follow on LinkedIn, or follow WoltersKluwerComms on YouTube.